Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence
Authors
Keywords
-
Journal
CLINICAL DRUG INVESTIGATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-04
DOI
10.1007/s40261-019-00793-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics
- (2018) Carlos R Camara-Lemarroy et al. BRAIN
- Spasticity Treatment Ameliorates the Efficacy of Melatonin Therapy in Experimental Autoimmune Encephalomyelitis (EAE) Mouse Model of Multiple Sclerosis
- (2018) Majid Ghareghani et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Preservation of neuronal function as measured by clinical and MRI endpoints in relapsing-remitting multiple sclerosis: how effective are current treatment strategies?
- (2018) Christiane Graetz et al. Expert Review of Neurotherapeutics
- Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis
- (2018) Graham Campbell et al. FEBS LETTERS
- Neuroprotective Effects of Melatonin on Experimental Allergic Encephalomyelitis Mice Via Anti-Oxidative Stress Activity
- (2018) Ting Long et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Preservation of neuronal function as measured by clinical and MRI endpoints in relapsing-remitting multiple sclerosis: how effective are current treatment strategies?
- (2018) Christiane Graetz et al. Expert Review of Neurotherapeutics
- Melatonin pharmacokinetics after transdermal administration changes according to the time of the day
- (2017) Ana Flo et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Regulating the balance between the kynurenine and serotonin pathways of tryptophan metabolism
- (2017) Yang Li et al. FEBS Journal
- Melatonin therapy reduces the risk of osteoporosis and normalizes bone formation in multiple sclerosis
- (2017) Majid Ghareghani et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Melatonin reduces inflammatory response in peripheral T helper lymphocytes from relapsing-remitting multiple sclerosis patients
- (2017) Nuria Álvarez-Sánchez et al. JOURNAL OF PINEAL RESEARCH
- Oxidative Modification of Blood Serum Proteins in Multiple Sclerosis after Interferon Beta and Melatonin Treatment
- (2017) Monika Adamczyk-Sowa et al. Oxidative Medicine and Cellular Longevity
- Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases
- (2017) Patrick Peschl et al. Frontiers in Immunology
- Melatonin as an Antioxidant for Stroke Neuroprotection
- (2016) Nate Watson et al. CELL TRANSPLANTATION
- Melatonin exacerbates acute experimental autoimmune encephalomyelitis by enhancing the serum levels of lactate: A potential biomarker of multiple sclerosis progression
- (2016) Majid Ghareghani et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Pharmacokinetics of a novel dosing regimen of oral melatonin in critically ill patients
- (2016) Judith Bellapart et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis
- (2016) Shyi-Jou Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis
- (2016) Jie Wen et al. Journal of Neuroimmune Pharmacology
- Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes
- (2016) Solaleh Emamgholipour et al. LIFE SCIENCES
- Melatoninergic System in Parkinson’s Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms
- (2016) Josiel Mileno Mack et al. Oxidative Medicine and Cellular Longevity
- Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance
- (2015) Nuria Álvarez-Sánchez et al. BRAIN BEHAVIOR AND IMMUNITY
- Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses
- (2015) Mauricio F. Farez et al. CELL
- The Blood-Brain Barrier in Multiple Sclerosis: microRNAs as Key Regulators
- (2015) Wouter Kamphuis et al. CNS & Neurological Disorders-Drug Targets
- Pathological mechanisms in progressive multiple sclerosis
- (2015) Don H Mahad et al. LANCET NEUROLOGY
- The Effect of Melatonin on Behavioral, Molecular, and Histopathological Changes in Cuprizone Model of Demyelination
- (2015) Gelareh Vakilzadeh et al. MOLECULAR NEUROBIOLOGY
- Why does multiple sclerosis only affect human primates?
- (2015) Bert A ‘t Hart Multiple Sclerosis Journal
- Multiple sclerosis—a quiet revolution
- (2015) Richard M. Ransohoff et al. Nature Reviews Neurology
- Why does multiple sclerosis only affect human primates?
- (2015) Bert A ‘t Hart Multiple Sclerosis Journal
- The role of melatonin in diabetes: therapeutic implications
- (2015) Shweta Sharma et al. Archives of Endocrinology Metabolism
- Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing- Remitting Multiple Sclerosis
- (2015) Roberta Mancuso et al. PLoS One
- Role of the Blood–Brain Barrier in Multiple Sclerosis
- (2014) Genaro Gabriel Ortiz et al. ARCHIVES OF MEDICAL RESEARCH
- Osteoporosis and Multiple Sclerosis: Risk Factors, Pathophysiology, and Therapeutic Interventions
- (2014) Sahil Gupta et al. CNS DRUGS
- Multiple Sclerosis: Current Knowledge and Future Outlook
- (2014) Christian P. Kamm et al. EUROPEAN NEUROLOGY
- Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies
- (2014) Gayathri Sundaram et al. Journal of Neuroinflammation
- N-Acetyl-Serotonin Offers Neuroprotection through Inhibiting Mitochondrial Death Pathways and Autophagic Activation in Experimental Models of Ischemic Injury
- (2014) H. Zhou et al. JOURNAL OF NEUROSCIENCE
- Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies
- (2014) Dean M. Wingerchuk et al. MAYO CLINIC PROCEEDINGS
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis
- (2014) Iraj Ragerdi Kashani et al. EXPERIMENTAL BRAIN RESEARCH
- Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course
- (2013) Elżbieta Miller et al. JOURNAL OF NEUROIMMUNOLOGY
- JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reperfusion injury
- (2013) Yang Yang et al. JOURNAL OF PINEAL RESEARCH
- Melatonin pathway genes are associated with progressive subtypes and disability status in multiple sclerosis among Finnish patients
- (2012) Renuka Natarajan et al. JOURNAL OF NEUROIMMUNOLOGY
- Melatonin Antioxidative Defense: Therapeutical Implications for Aging and Neurodegenerative Processes
- (2012) Seithikurippu R. Pandi-Perumal et al. NEUROTOXICITY RESEARCH
- Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
- (2011) Cris S Constantinescu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Involvement of kynurenines in Huntington’s disease and stroke-induced brain damage
- (2011) Trevor W. Stone et al. JOURNAL OF NEURAL TRANSMISSION
- Interleukin-6 autocrine signaling mediates melatonin MT1/2receptor-induced STAT3 Tyr705phosphorylation
- (2011) Winnie W. I. Lau et al. JOURNAL OF PINEAL RESEARCH
- Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis
- (2011) Lena Melamud et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Clinical Aspects of Melatonin Intervention in Alzheimers Disease Progression
- (2010) Daniel P. Cardinali et al. Current Neuropharmacology
- Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin
- (2010) G. Anderson et al. EUROPEAN JOURNAL OF NEUROLOGY
- Melatonin treatment normalizes plasma pro-inflammatory cytokines and nitrosative/oxidative stress in patients suffering from Duchenne muscular dystrophy
- (2010) Mariam Chahbouni et al. JOURNAL OF PINEAL RESEARCH
- Oligodendrocytes: biology and pathology
- (2009) Monika Bradl et al. ACTA NEUROPATHOLOGICA
- The cuprizone model for demyelination
- (2008) Ø. Torkildsen et al. ACTA NEUROLOGICA SCANDINAVICA
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials
- (2008) Shantha MW Rajaratnam et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More